Drugs recently released in Belgium. Octreotide--roxithromycin.
Harvengt
C
C
D006801:Humans; D015282:Octreotide / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D015575:Roxithromycin / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*
D015575:Roxithromycin; D015282:Octreotide